Last reviewed · How we verify
NCT03747627: BPF GILD
BPF Genetics of ILD Study
trial testing Genetic profiling in Lung; Disease, Interstitial, With Fibrosis in 475 participants. Participants enrolled and being followed up; not accepting new ones.
19 January 2025
Quick facts
| Lead sponsor | University of Dundee |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 475 |
| Start date | 19 January 2019 |
| Primary completion | 19 January 2025 |
| Estimated completion | 1 January 2028 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Genetic profiling
Conditions studied
- Lung; Disease, Interstitial, With Fibrosis — all drugs for Lung; Disease, Interstitial, With Fibrosis →
- Alveolitis, Extrinsic Allergic — all drugs for Alveolitis, Extrinsic Allergic →
- Bird Fancier's Lung — all drugs for Bird Fancier's Lung →
- Idiopathic Interstitial Pneumonias — all drugs for Idiopathic Interstitial Pneumonias →
Sponsor
University of Dundee
Who can join
Adults 18 to 80, any sex, with Lung; Disease, Interstitial, With Fibrosis or Alveolitis, Extrinsic Allergic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aim to examine the genetic determinants of interstitial lung disease in a cohort of subjects with regular exposure to pigeons, a known cause of one form of interstitial lung disease known as hypersensitivity pneumonitis. In addition we will examine immunological causes for hypersensitivity pneumonitis in this group. We anticipate our work will provide insights of use to clinicians and patients with hypersensitivity pneumonitis and other interstitial lung diseases.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03747627
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung; Disease, Interstitial, With Fibrosis
Currently open trials in the same condition.
- NCT06482190 — A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers · Phase 1 · recruiting
- NCT05318599 — Deep Learning Diagnostic and Risk-stratification for IPF and COPD · recruiting
- NCT03752892 — Partitioned Training of Patients With Idiopathic Pulmonary Fibrosis · NA · active not recruiting
Other University of Dundee trials
Trials by the same sponsor.
- NCT06435156 — Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes · Phase 2 · recruiting
- NCT05582798 — Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function · Phase 4 · completed
- NCT04419805 — Single Palatal Temporary Anchorage Device for Anterior Open Bite · NA · unknown
- NCT03747107 — Pharmacist and Data Driven Quality Improvement in Primary Care · completed
- NCT04817332 — STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19 · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03747627 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Dundee
- Last refreshed: 25 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03747627.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing